FDA Inspection 1105484 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on Aug 23, 2019 in Lincoln Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln Park, NJ (United States)